vimarsana.com

Page 8 - உலகம் பெரும்பாலானவை புதுமையானது நிறுவனங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lineage Logistics to acquire cold storage division in Europe – Produce Blue Book

Lineage Logistics to acquire cold storage division in Europe – Produce Blue Book
producebluebook.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from producebluebook.com Daily Mail and Mail on Sunday newspapers.

TBWA Bolsters Intelligence and Data Talent with Two Key Hires

Lineage Logistics Announces Acquisition of Kloosterboer Group

Lineage Logistics, LLC (“Lineage” or the “Company”), one of the world’s leading and most innovative temperature-controlled industrial REIT and logistics solutions providers, today announced it has reached an agreement to acquire Kloosterboer Group (“Kloosterboer”), a leading independent integrated platform for temperature-controlled storage, logistics and value-added services in Europe.

Honeywell to own majority stake in joint venture with Cambridge Quantum Computing

Honeywell to own majority stake in joint venture with Cambridge Quantum Computing
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

Kantaro s Semi-Quantitative Antibody Test Kit Receives Health Canada Authorization Under the COVID-19 Interim Order

Share this article   - COVID-SeroKlir detects both the presence and precise level of neutralizing IgG antibodies with 98.8% sensitivity and 99.6% specificity- -Available immediately and can be used in Canadian laboratories without proprietary equipment- NEW YORK, June 2, 2021 /PRNewswire/ Kantaro Biosciences, LLC (Kantaro), a joint venture between the Mount Sinai Health System and RenalytixAI (LSE: RENS /NASDAQ: RNLX), and its commercial partner Bio-Techne Corporation (NASDAQ: TECH), have received Health Canada Authorization under the COVID-19 Interim Order for COVID-SeroKlir, its semi-quantitative SARS-CoV-2 IgG antibody test kit. COVID-SeroKlir measures the presence and precise level of spike protein IgG antibodies. These are neutralizing antibodies produced as part of the immune response to COVID-19 virus exposure or generated by a vaccine and may help prevent (re-)infection. The Mount Sinai Health System in New York City developed the test s underlying technology,

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.